Browsing by Author "Anlar, Ö."

Now showing 1 - 3 of 3

Cerebral Hemiatrophy Associated With Hematological and Developmental Disorders
(2004) Ünal, Ö.; Çaksen, H.; Kiymaz, N.; Dilek, I.; Kayan, M.; Anlar, Ö.
The etiology of cerebral hemiatrophy may be congenital or acquired. Trauma, infection, vascular abnormality, ischemic and hemorrhagic conditions may be the etiologic factors in acquired type. There is limited information about its association with other disorders in the literature. We presented three new cases of cerebral hemiatrophy associated with some hematological and developmental disorders. Cerebral hemiatrophy was associated with thalassemia major in a 10-year-old girl, acute myeloblastic leukemia and Marfan syndrome in a 23-year-old man, and craniosynostosis in a 1-year-old boy. To the best of our knowledge, thalassemia major, myeloblastic leukemia, Marfan syndrome and craniosynostosis have not been reported in cerebral hemiatrophy in the literature. © 2004, IOS Press. All rights reserved.
Disposable Concentric Needle Electromyography Electrodes Artifact Discharge Mimicking Positive Sharp Waves
(2003) Anlar, Ö.; Baslo, M.B.; Ertaş, M.; Oge, A.E.; Yazici, J.
Objectives: To determine a new artifact discharge produced from the disposable concentric needle (DCN) electromyography (EMG) electrodes. Methods: We have recorded the activity obtained after the first insertion of 41 DCN (37 mm) and 36 DCN (50 mm) in several muscles during the rest. The number of the patients was 77 (26 male, 51 female). Results: We observed an artifact discharge (AD) resembling positive sharp waves (PSWs) in 31 patients of 77 insertions. The AD occurred with 18 of 41 insertions of DCN 37 mm and 13 of DCN 50 mm. The artifact resolved when the needle has been moved in the muscle or in the adipose subcutaneous tissue. Conclusion: This AD should be recognized when using DCN electrodes to avoid confusion with PSWs. Recognizing these artifacts during needle EMG is important to avoid false positive results.
Intravenous Aspirin Use in Migraine Attacks
(Turkish Society of Cerebrovascular Diseases, 2003) Anlar, Ö.; Tombul, T.; Kisli, M.
Aspirin is an efficient and cheap analgesic drug, which is used frequently. It is given orally in our country up to date. Use of aspirin intravenously in migraine headache has recently been tried and satisfying results were reported. Thirty-five patients with migraine attacks were admitted to emergency service. Twenty-three patients were treated by 900 mg Lysine acetylsalicylate (LASA)-equivalent of 500 mg aspirin intravenously (I.V). Twelve patients were treated by subcutaneous (S.C) injection of 6 mg sumatriptan. In the patients treated with LASA, the headache relieved clearly in 15 (62.5%) within 4-15 minutes. A moderate pain relief was obtained in 4 patients (17.4%) and there was slight improvement headache in 3 patients (13.1%). There was no response in one patient (4.3%). The pain was disappeared within 30-120 minutes in ten patients (83%) who were treated by sumatriptan. Sumatriptan was not beneficial in two patients (17%). Because of its rapid action and low cost, LASA I.V can be accepted as an effective therapy in migraine attacks treatment.